Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II Chemotherapy with INOX for Metastatic Breast Cancer Refractory to Standard Agents

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								SEG-BRE-P48


2.		Phase II Study of Diglycoaldehyde for Acute Leukemia in Adults

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18				NCI				SWOG-7723


3.		Phase II Study of Diglycoaldehyde for Metastatic Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-7724


4.		Phase II Chemotherapy with Diglycoaldehyde for Acute Leukemia and Solid Tumor Resistant to Standard Therapy in Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				under 18				NCI				CCG-052


5.		Pilot-Phase II Chemotherapy with INOX for Advanced Testicular Cancer, Melanoma, Oat Cell Carcinoma, and Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				CLB-7701


6.		Phase I Chemotherapy with Diglycoaldehyde for Leukemia and Solid Tumors in Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				under 18				NCI				CCG-040


7.		MeCCNU Plus TGDR, VP-16 and INOX Chemotherapy for Previously Treated Recurrent or Metastatic Colorectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Completed				no age specified				NCI				EST-1275

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute